Restenosis after successful coronary balloon angioplasty (PTCA) or stenting, usually within the first 6 months, continues to be a major limitation and a therapeutic challenge. Recent studies have identified negative vascular remodeling (for nonstent transcatheter procedures) and neointimal hyperplasia (for in-stent restenosis) as the mechanisms of restenosis. New therapies, such as coronary stents, atheroablative devices, intracoronary irradiation, and local drug delivery, may improve the treatment of restenosis. This review article discusses the therapeutic options for patients with restenosis after coronary angioplasty or stent implantation.
|Number of pages||12|
|Journal||Contemporary Treatments in Cardiovascular Disease|
|State||Published - 1998|